# Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

> **NCT05490888** · PHASE1 · RECRUITING · sponsor: **PharmaIN** · enrollment: 74 (estimated)

## Conditions studied

- Cirrhosis, Liver
- Liver Fibrosis
- Ascites Hepatic

## Interventions

- **DRUG:** PHIN-214 Subcutaneous injection

## Key facts

- **NCT ID:** NCT05490888
- **Lead sponsor:** PharmaIN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-03
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05490888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05490888, "Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05490888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*